K2 Principal Fund, L.P. Abb Vie Inc. Call Options Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $2.1 Million - $2.34 Million	-20,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $511,500 - $563,100	-5,000 Reduced 20.0%	20,000 $2.16 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $2.15 Million - $2.52 Million	25,000 New	25,000 $2.19 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.